Emiliano Cocco Selected Research

hI-con1

10/2011	Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
6/2011	Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emiliano Cocco Research Topics

Disease

51	Neoplasms (Cancer) 05/2024 - 07/2009
29	Carcinoma (Carcinomatosis) 01/2023 - 07/2009
11	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 07/2010
8	Papillary Carcinoma 01/2019 - 01/2010
7	Endometrial Neoplasms (Endometrial Cancer) 10/2018 - 02/2010
6	Breast Neoplasms (Breast Cancer) 05/2024 - 10/2018
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2019 - 07/2009
5	Carcinosarcoma 10/2016 - 05/2012
5	Ovarian Diseases (Ovarian Disease) 12/2015 - 07/2009
3	Ascites 01/2016 - 07/2010
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2020
2	Adenocarcinoma 11/2019 - 06/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2019 - 06/2011
2	Bites and Stings (Sting) 01/2016 - 02/2015
2	Ovarian Epithelial Carcinoma 02/2015 - 07/2009
2	Endometrioid Carcinoma 12/2011 - 02/2010
1	Atrophy 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Triple Negative Breast Neoplasms 09/2021
1	Residual Neoplasm 09/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 10/2018 - 07/2009
7	Epithelial Cell Adhesion MoleculeIBA 01/2016 - 07/2009
7	Monoclonal AntibodiesIBA 05/2012 - 07/2009
6	Claudin-3IBA 01/2019 - 07/2010
6	Messenger RNA (mRNA)IBA 12/2011 - 01/2010
5	Phosphotransferases (Kinase)IBA 01/2021 - 11/2013
5	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 10/2014
5	Clostridium enterotoxinIBA 01/2017 - 07/2010
4	Estrogen ReceptorsIBA 05/2024 - 01/2019
4	larotrectinibIBA 01/2023 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 09/2021 - 02/2010
4	neratinibIBA 11/2019 - 10/2014
4	Claudin-4IBA 01/2019 - 07/2010
4	Trastuzumab (Herceptin)FDA Link 10/2018 - 05/2012
4	PlatinumIBA 01/2017 - 08/2010
4	Peptides (Polypeptides)IBA 12/2015 - 07/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2014 - 10/2010
4	epothilone B (EPO906)IBA 01/2014 - 10/2010
4	Interleukin-2 (IL2)IBA 12/2011 - 12/2010
3	SolitomabIBA 01/2016 - 02/2015
3	TubulinIBA 01/2014 - 07/2013
3	adecatumumabIBA 12/2010 - 01/2010
2	AlpelisibIBA 05/2024 - 01/2022
2	ChromatinIBA 05/2024 - 10/2020
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 02/2013
2	AfatinibIBA 11/2019 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 10/2018 - 07/2015
2	ChromiumIBA 01/2016 - 02/2015
2	CytokinesIBA 01/2016 - 10/2015
2	HLA-DR Antigens (HLA-DR)IBA 01/2016 - 10/2015
2	Fluorescein-5-isothiocyanate (FITC)IBA 12/2015 - 07/2010
2	Membrane Proteins (Integral Membrane Proteins)IBA 10/2015 - 04/2015
2	AntigensIBA 10/2015 - 07/2009
2	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 10/2015 - 07/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2013 - 11/2013
2	taxaneIBA 07/2013 - 07/2013
2	Epothilones (Epothilone)IBA 07/2013 - 07/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2013 - 07/2013
2	Complement System Proteins (Complement)IBA 05/2012 - 10/2011
2	Small Interfering RNA (siRNA)IBA 12/2011 - 10/2011
2	hI-con1IBA 10/2011 - 06/2011
2	A-factor (Streptomyces)IBA 10/2011 - 06/2011
2	Thromboplastin (Tissue Factor)IBA 10/2011 - 06/2011
2	Rituximab (Mabthera)FDA Link 07/2011 - 06/2011
2	RNA (Ribonucleic Acid)IBA 07/2009 - 07/2009
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2024
1	Hormones (Hormone)IBA 05/2024
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2024
1	Circulating Tumor DNAIBA 03/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Tromethamine (Trometamol)FDA Link 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	selpercatinibIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2021
1	AntibodiesIBA 09/2021
1	Transcription Factors (Transcription Factor)IBA 10/2020
1	Aromatase InhibitorsIBA 10/2020
1	trastuzumab deruxtecanIBA 01/2020
1	Ado-Trastuzumab EmtansineIBA 01/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	copanlisibIBA 11/2019
1	Cytidine DeaminaseIBA 11/2019
1	MethyltransferasesIBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	Keratin-7 (Cytokeratin 7)IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	entrectinibIBA 12/2018
1	Lapatinib (GW572016)FDA Link 10/2018

Therapy/Procedure

24	Therapeutics 05/2024 - 07/2009
22	Drug Therapy (Chemotherapy) 07/2022 - 07/2009
13	Immunotherapy 01/2020 - 07/2009
2	Neoadjuvant Therapy 09/2021 - 12/2015
1	Radiotherapy 07/2022
1	Heterologous Transplantation (Xenotransplantation) 01/2019